| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.06B | +12.0% |
| Gross profit | ¥0.02B | — |
| Operating income | ¥-0.02B | — |
| Net income | ¥-0.02B | — |
| Gross margin | 27.1% | Net margin -27.0% |
| Revenue Q/Q | +140.4% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.04B | 72.9% |
| SG&A | ¥0.03B | 47.1% |
| Tax & other | ¥-0.00B | -2.0% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
新光药业 ・ 科大国创 ・ 爱司凯 ・ 世名科技 ・ 辰安科技 ・ 博思软件 ・ ST应急 ・ 幸福蓝海 ・ 健帆生物 ・ 领湃科技 ・ 优博讯 ・ 今天国际
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies